Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medicines originally developed for type 2 diabetes management but increasingly recognised for their effects on body composition, including visceral fat reduction
Some patients benefit from more frequent, smaller shipments rather than bulk ordersespecially if they're in early titration phases with changing doses
All GLP-1 receptor agonists and tirzepatide carry a boxed warning for risk of thyroid C-cell tumors and are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
When in doubt, contact Strive Pharmacy directly
503A pharmacies are traditional compounding pharmacies regulated by state boards
